SCHEMBL567236

SCHEMBL567236

CC(CO)(CCc1ccccc1)NC(=O)O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.47
RAB9A P51151 5/20 0.47
MAPT P10636 1/20 0.47
SSTR4 P31391 1/20 0.46
POLB P06746 1/20 0.44
ALDH1A1 P00352 4/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
CYP3A4 P08684 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4297214 0.87 KDM4E (0.42) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL4297210 0.87 KDM4E (0.42) NPC1RAB9AALDH1A1CYP3A4MEN1
SCHEMBL13614219 0.84 CA12 (0.51) NPC1RAB9AMAPTSSTR4CA12
SCHEMBL2875453 0.84 NPC1 (0.45) NPC1RAB9AMAPTSSTR4POLB
SCHEMBL16162058 0.83 CYP3A4 (0.49) NPC1RAB9AMAPTALDH1A1CYP3A4
SCHEMBL4025551 0.83 CYP3A4 (0.49) NPC1RAB9AMAPTALDH1A1CYP3A4
SCHEMBL4596217 0.81 NPC1 (0.45) NPC1RAB9AMAPTSSTR4POLB
SCHEMBL687546 0.77 PPARA (0.48) NPC1ALDH1A1KMT2A
SCHEMBL687545 0.77 PPARA (0.48) NPC1ALDH1A1KMT2A
SCHEMBL12721396 0.74 NPC1 (0.44) NPC1RAB9AMAPTTDP1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444395-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVE WESTERN THERAPEUTICS INST INC D (JP) 2016-01-06 EP disclosed
US-8951997-B2 Substituted isoquinoline derivative D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) 2015-02-10 US disclosed
EP-2444395-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE D. Western Therapeutics Institute, Inc. (JP) 2012-04-25 EP disclosed
US-20120035159-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE D. WESTERN THERAPEUTICS INSTITUTE, INC (JP) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035159-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE SULT1A1, SULT1E1, SULT2A1 NPC1 1307/4885RAB9A 3306/4885MAPT 4257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.